Challenges in the management of localized Ewing sarcoma in a developing country

References

• PDQ Pediatric Treatment Editorial Board. Ewing sarcoma treatment (PDQ®): health professional version. PDQ Cancer Information Summaries. Bethesda, MD: National Cancer Institute (US); 2002. http://www.ncbi.nlm.nih.gov/books/NBK66045/. Accessed November 4, 2018.
   Google Scholar
• Bajpai J, Khanna N, Vora T, et al. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes. Indian J Cancer. 2018;55(1):37–44. doi:10.4103/ijc.IJC_481_17.
   PubMed Web of Science ®Google Scholar
• Becker RG, Gregianin LJ, Galia CR, et al. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1. BMC Cancer. 2017;17(1):420. doi:10.1186/s12885-017-3391-5.
   PubMedGoogle Scholar
• Israels T, Challinor J, Howard S, Arora RH. Treating children with cancer worldwide-challenges and interventions. Pediatrics. 2015;136(4):607–610. doi:10.1542/peds.2015-0300.
   PubMed Web of Science ®Google Scholar
• Gaspar N, Hawkins DS, Dirksen U, et al. Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol. 2015;33(27):3036–3046. doi:10.1200/JCO.2014.59.5256.
   PubMed Web of Science ®Google Scholar
• Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348(8):694–701. doi:10.1056/NEJMoa020890.
   PubMed Web of Science ®Google Scholar
• Karski EE, McIlvaine E, Segal MR, et al. Identification of discrete prognostic groups in Ewing Sarcoma. Pediatr Blood Cancer. 2016;63(1):47–53. doi:10.1002/pbc.25709.
   PubMed Web of Science ®Google Scholar
• Worch J, Ranft A, DuBois SG, Paulussen M, Juergens H, Dirksen U. Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Pediatr Blood Cancer. 2018;65(9):e27251. doi:10.1002/pbc.2725.
   PubMed Web of Science ®Google Scholar
• Huh WW, Daw NC, Herzog CE, Munsell MF, McAleer MF, Lewis VO. Ewing sarcoma family of tumors in children younger than 10 years of age. Pediatr Blood Cancer. 2017;64(4):e26275. doi:10.1002/pbc.26275.
   Web of Science ®Google Scholar
• Goyal S, Roscoe J, Ryder WDJ, Gattamaneni HR, Eden T. Symptom interval in young people with bone cancer. Eur J Cancer. 2004;40(15):2280–2286. doi:10.1016/j.ejca.2004.05.017.
   PubMed Web of Science ®Google Scholar
• Ferrari A, Miceli R, Casanova M, et al. The symptom interval in children and adolescents with soft tissue sarcomas. Cancer. 2009;116:NA–83. doi:10.1002/cncr.24695.
   Web of Science ®Google Scholar
• Friedrich P, Ortiz R, Fuentes S, et al. Barriers to effective treatment of pediatric solid tumors in middle-income countries: can we make sense of the spectrum of nonbiologic factors that influence outcomes? Cancer. 2014;120(1):112–125. doi:10.1002/cncr.28339.
   PubMed Web of Science ®Google Scholar
• Faruqui N, Joshi R, Lowe J, et al. Exploring barriers to accessing care for childhood cancers in India: a qualitative study (Inpog-Acc-16-03). Pediatr Hematol Oncol J. 2018;3(3):S1–S2. doi:10.1016/j.phoj.2018.11.004.
   Google Scholar
• Friedrich P, Ortiz R, Strait K, et al. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement. Cancer. 2013;119(4):871–879. doi:
   PubMed Web of Science ®Google Scholar
• Bhargav A, Singh U, Trehan A, Zadeng Z, Bansal D. Female sex, bilateral disease, age below 3 years, and apprehension for enucleation contribute to treatment abandonment in retinoblastoma. J Pediatr Hematol Oncol. 2017;39(5):e249–53. doi:10.1097/MPH.0000000000000856..
   PubMed Web of Science ®Google Scholar
• Bansal D, Das A, Trehan A, et al. Pediatric rhabdomyosarcoma in India: a single-center experience. Indian Pediatr. 2017;54(9):735–738. doi:10.1007/s13312-017-1164-5.
   PubMed Web of Science ®Google Scholar
• Friedrich P, Lam CG, Itriago E, Perez R, Ribeiro RC, Arora RS. Magnitude of treatment abandonment in childhood cancer. PLoS One. 2015;10(9):e0135230. doi:10.1371/journal.pone.0135230.
   PubMed Web of Science ®Google Scholar
• Whelan J, Hackshaw A, McTiernan A, et al. Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92. Clin Sarcoma Res. 2018;8:6. doi:10.1186/s13569-018-0093-y.
   PubMed Web of Science ®Google Scholar
• Bonilla M, Moreno N, Marina N, et al. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol. 2000;22:495–501. doi:10.1097/00043426-200011000-00004.
   PubMed Web of Science ®Google Scholar
• Trehan A, Bansal D, Varma N, Vora A. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India. Pediatr Blood Cancer. 2017;64(4):e26281. doi:10.1002/pbc.26281.
   Web of Science ®Google Scholar
• Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer. 2005;41(11):1570–1583. doi:10.1016/j.ejca.2004.11.004.
   PubMed Web of Science ®Google Scholar
• Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer. 2011;117(20):4788–4795. doi:10.1002/cncr.26107.
   PubMed Web of Science ®Google Scholar
• DuBois SG, Krailo MD, Gebhardt MC, et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children’s Oncology Group. Cancer. 2015;121(3):467–475. doi:10.1002/cncr.29065.
   PubMed Web of Science ®Google Scholar
• Gupta AA, Pappo A, Saunders N, et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010;116(13):3189–3194. doi:10.1002/cncr.25144.
   PubMed Web of Science ®Google Scholar
• Delepine G, Delepine N, Delepine F, Guikov E, Markowska B, Alkallaf S. Prognostic value of timing of surgery in localised Ewing’s sarcoma of bone. Orthop Proc. 2002;84-B:119–119. https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.84BSUPP_II.0840119b
   Google Scholar
• Kreyer J, Ranft A, Timmermann B, et al. Impact of the interdisciplinary tumor board of the cooperative Ewing sarcoma study group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Pediatr Blood Cancer. 2018;65(12):e27384. doi:10.1002/pbc.27384.
   PubMed Web of Science ®Google Scholar
• Howard SC, Davidson A, Luna-Fineman S, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: the pediatric oncology in developing countries (PODC) committee of the international pediatric oncology society (SIOP). Pediatr Blood Cancer. 2017;64:e26879. doi:10.1002/pbc.26879.
   Web of Science ®Google Scholar
• Parkes J, Hess C, Burger H, et al. Recommendations for the treatment of children with radiotherapy in low- and middle-income countries (LMIC): a position paper from the Pediatric Radiation Oncology Society (PROS-LMIC) and Pediatric Oncology in Developing Countries (PODC) working groups of the International Society of Pediatric Oncology (SIOP. Pediatr Blood Cancer. 2017;64:e26903. doi:10.1002/pbc.26903.
   Web of Science ®Google Scholar